Dementia

Have you or someone you know well been affected by Mild Cognitive Impairment or Mild Dementia, due to probable or possible Alzheimer Disease?

Skills / interests: Review development, Patient and public input

Would you be interested in helping us with a Cochrane systematic review focused on amyloidβ-targeting monoclonal antibodies (Aβ-mAbs) for the treatment of people with Mild Cognitive Impairment (MCI) or mild dementia due to Alzheimer’s disease (AD)?

We are looking for a consumer who would be willing to join our Cochrane systematic review, supporting the author team with:

  • Carrying out the review;
  • Interpretation of the review findings;
  • Drafting of the Plain Language Summary.

Cochrane considers a consumer to be a person with experience of the condition (in this case, MCI or mild dementia due to Alzheimer’s disease), either as a patient or as a carer/family member of a patient.

If you any questions and would like more info about the task, write to cochrane.italia@ausl.bologna.it

Ideal applicant

A person with experience of the condition (in this case, Mild Cognitive Impairment or Mild Dementia, due to probable or possible Alzheimer Disease), either as a patient or as a carer/family member of a patient.

Think you've got what it takes to get the job done for Claudia?

Log in
to respond

Questions & comments